Merck research facility
Executive Summary
The new 264,000 sq. ft., $80 mil. facility will be a center for such development projects as: MK-906, a reducing agent for enlarged prostate glands; a wound healing agent; leukotrienes; and genetically engineered vaccines. The facility, located at Merck's headquarters in Rahway, N.J., was dedicated to former chairman and CEO John Horan on June 19. The building's 70 main laboratories will house a research staff of 300.